C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2007
12/12/2007	EP1863771A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
12/12/2007	EP1863483A1 Bicyclic pyrazole compounds as antibacterial agents
12/12/2007	EP1752452A9 Propane-1,3-dione derivative or its salt
12/12/2007	EP1644357B1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/12/2007	EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
12/12/2007	EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
12/12/2007	EP1276738B1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
12/12/2007	CN101087783A Trisubstituted thiophenes as progesterone receptor modulators
12/12/2007	CN101087782A (2-carboxamido)(3-amino) thiophene compounds
12/12/2007	CN101087781A Indole derivatives for treating pulmonary tuberculosis
12/12/2007	CN101087780A Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs
12/12/2007	CN101087773A Inhibitors of c-fms kinase
12/12/2007	CN101087768A Thrombopoietin activity modulating compounds and methods
12/12/2007	CN101087766A Pyridazine compounds, compositions and methods
12/12/2007	CN101087764A Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents
12/12/2007	CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007	CN101087609A Factor Xa compounds
12/12/2007	CN101085760A Ligustrazine stilbenoids derivatives, preparation method thereof, medicament composition and use
12/12/2007	CN101085759A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/12/2007	CN100354263C Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
12/12/2007	CN100353942C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
12/11/2007	US7307173 E.g., 3-(2-(p-dibutylaminostyryl)thiophen-5-ylvinylene)-4-cyano-5-dicyanomethylene-2-pyrrolinone or similar thiazole derivatives; organic nonlinear optical applications
12/11/2007	US7307074 Diazepan derivatives or salts thereof
12/06/2007	WO2007140197A1 Therapeutic pyrrolidine compounds
12/06/2007	WO2007140174A2 Compounds and methods for modulating fxr
12/06/2007	WO2007139955A2 Triazole compounds that modulate hsp90 activity
12/06/2007	WO2007139816A2 Thiophene-carboxamides useful as inhibitors of protein kinases
12/06/2007	WO2007139795A1 Thiophene-carboxamides useful as inhibitors of protein kinases
12/06/2007	WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof
12/06/2007	WO2007138112A2 Compounds that interact with ion channels, in particular with ion channels from the kv family
12/06/2007	WO2007137790A1 Isoindolin-1-one-, isoindolin-3-one- and isoindolin-1,3-dione-derivatives and use thereof
12/06/2007	WO2007105053A3 Tetralines antagonists of the h-3 receptor
12/06/2007	WO2006067428A3 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
12/06/2007	US20070282101 Indazole compounds
12/06/2007	US20070281946 Tri(cyclo) substituted amide compounds
12/06/2007	US20070281936 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide
12/06/2007	US20070281930 bicyclic bisamides for controlling acarina
12/06/2007	DE102007019022A1 Farbstoff für farbstoffsensibilisierte Solarzelle und daraus hergestellte Solarzelle Dye for dye-sensitized solar cell and solar cell made therefrom
12/06/2007	DE102006025316A1 Isoindolin-1-on-, Isoindolin-3-on- und Isoindolin-1,3-dion-Derivate und ihre Verwendung Isoindoline-1-one, isoindoline-3-one and isoindoline-1,3-dione derivatives and their use
12/06/2007	DE102006025314A1 Arylsubstituierte Heterozyklen und ihre Verwendung Aryl-substituted heterocycles and their use
12/06/2007	CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof
12/06/2007	CA2653665A1 Isoindolin-1-one, isoindolin-3-one and isoindoline-1,3-dione-derivatives and their use
12/06/2007	CA2653223A1 Therapeutic pyrrolidine compounds
12/06/2007	CA2653222A1 Triazole compounds that modulate hsp90 activity
12/06/2007	CA2653005A1 Thiophene-carboxamides useful as inhibitors of protein kinases
12/06/2007	CA2652816A1 Thiophene-carboxamides useful as inhibitors of protein kinases
12/06/2007	CA2651373A1 Compounds and methods for modulating fxr
12/05/2007	EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007	EP1861399A2 Cgrp receptor antagonists
12/05/2007	EP1861392A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
12/05/2007	EP1861380A1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
12/05/2007	EP1861378A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
12/05/2007	EP1861372A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
12/05/2007	EP1861371A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase.
12/05/2007	EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
12/05/2007	EP1554262B1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
12/05/2007	EP1433479B1 Appetite-stimulating agents and remedies for anorexia
12/05/2007	EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007	EP1368318B1 Calcilytic compounds
12/05/2007	EP1208085B1 Benzanilides as potassium channel openers
12/05/2007	EP1137642B1 Bis-sulfonamides
12/05/2007	CN101084198A Substituted amino-pyrimidones and uses thereof
12/05/2007	CN101084195A 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
12/05/2007	CN101084189A Indol derivatives as inhibitors of soluble adenylyl cyclase
12/05/2007	CN101081846A Quinazoline derivative and preparation method and usage thereof
12/05/2007	CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
12/05/2007	CN100353581C Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies
12/05/2007	CN100352817C Pyridinoylpiperidines as 5-HTLF agonists
12/05/2007	CN100352808C Heterocyclic diamide invertebrate pest control agents
12/05/2007	CN100352807C Chemical compounds
12/05/2007	CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/04/2007	US7304168 For tracing/imaging molecular transfer between cellular gap junctions
12/04/2007	US7304087 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/04/2007	US7304083 2-iminoimidazole derivatives (2)
12/04/2007	US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents
12/04/2007	US7304077 Asthma, rhinitis therapy
12/04/2007	US7304076 Dietetics; antidiabetic agents; eating disorders
12/04/2007	US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds
12/04/2007	US7304063 Inhibitors of Akt activity
12/04/2007	US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007	US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/04/2007	US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007	CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007	CA2418125C Beta-lactams useful in the preparation of substituted isoserine esters
12/04/2007	CA2280753C 1,4-substituted cyclic amine derivatives
11/2007
11/29/2007	WO2007137042A2 Process for preparing 7- (acryl0yl) -ind0les
11/29/2007	WO2007136703A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007	WO2007136302A2 Active substances, pharmaceutical composition and a method for the production and use thereof
11/29/2007	WO2007136300A2 Substituted indoles and a method for the production and use thereof
11/29/2007	WO2007136059A1 Composition for diagnosing amyloid-related disease
11/29/2007	WO2007135527A2 Benzimidazolyl compounds
11/29/2007	WO2007134862A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors
11/29/2007	WO2007120760A3 Thiophene-carboxamides useful as inhibitors of protein kinases
11/29/2007	WO2007095117A3 Method for improving the oral administration of alpha-lipoic acid
11/29/2007	WO2007090836A3 Piperidine derivatives as cxcr3 receptor antagonists
11/29/2007	WO2007090749A3 Benzamide and heteroarene derivatives as cetp inhibitors
11/29/2007	WO2007084413A3 Methods for treating hepatitis c
11/29/2007	WO2007014619A8 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
11/29/2007	WO2007006594A3 Reactive azo dyes, methods for the production thereof and their use
11/29/2007	US20070276141 Preparation of Pharmaceutical Salts of [1,4] - Bipiperidine

1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 523